The Â鶹´«Ã½ is part of a groundbreaking project looking to find an effective treatment for the symptoms of long COVID.
It is estimated that over two million people in the UK, and more than 144 million globally, are living with long COVID and almost a quarter of sufferers have experienced symptoms such as extreme fatigue and breathlessness, palpitations, and brain fog for more than two years.
The
ERASE – long COVID
trial, launched in September 2024 and led by the University of Derby, is the first of its kind in the UK, exploring whether anti-viral medications can be used as a treatment option for patients diagnosed with the condition.
The anti-viral medication being trialled is already used to treat people admitted to hospital with COVID-19, but as most people are not hospitalised with the condition, they do not have a way to access this medication.
This trial, involving 72 patients living with long COVID, will investigate whether it can alleviate some of the symptoms that people are living with.
The ERASE study is being managed by the
Peninsula Clinical Trials Unit (PenCTU)
at th